Skip to navigation menu Skip to content
Clinical Trial Search block Test

Primary Immune Regulatory Disorders (PIRD): Longitudinal Study of Clinical Presentation, Treatment and Outcomes

PIRD (Primary Immune Regulatory Disorders) PIDTC 6906

  • Phase: N/A
  • Clinicaltrials.gov ID: NA

What is the goal of the study?

The primary objective of this study is to estimate the overall survival (OS) of PIRD patients from the time of diagnosis.

Who can participate in the study?

Everyone

Study Team: